317 related articles for article (PubMed ID: 9521425)
21. Cloning of the putative tumour suppressor gene for hereditary multiple exostoses (EXT1).
Ahn J; Lüdecke HJ; Lindow S; Horton WA; Lee B; Wagner MJ; Horsthemke B; Wells DE
Nat Genet; 1995 Oct; 11(2):137-43. PubMed ID: 7550340
[TBL] [Abstract][Full Text] [Related]
22. [Molecular cloning of EXT2 and EXT4 gene].
Deng H; Xu L; Ruan Q; Huang L; Xia J
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):519-23. PubMed ID: 10806756
[TBL] [Abstract][Full Text] [Related]
23. Hereditary multiple exostoses: confirmation of linkage to chromosomes 8 and 11.
Blanton SH; Hogue D; Wagner M; Wells D; Young ID; Hecht JT
Am J Med Genet; 1996 Mar; 62(2):150-9. PubMed ID: 8882395
[TBL] [Abstract][Full Text] [Related]
24. Mutation screening of the EXT genes in patients with hereditary multiple exostoses in Taiwan.
Shi YR; Wu JY; Hsu YA; Lee CC; Tsai CH; Tsai FJ
Genet Test; 2002; 6(3):237-43. PubMed ID: 12490068
[TBL] [Abstract][Full Text] [Related]
25. Identification of novel mutations in the human EXT1 tumor suppressor gene.
Wells DE; Hill A; Lin X; Ahn J; Brown N; Wagner MJ
Hum Genet; 1997 May; 99(5):612-5. PubMed ID: 9150727
[TBL] [Abstract][Full Text] [Related]
26. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
27. Comparison of fluorescent single-strand conformation polymorphism analysis and denaturing high-performance liquid chromatography for detection of EXT1 and EXT2 mutations in hereditary multiple exostoses.
Dobson-Stone C; Cox RD; Lonie L; Southam L; Fraser M; Wise C; Bernier F; Hodgson S; Porter DE; Simpson AH; Monaco AP
Eur J Hum Genet; 2000 Jan; 8(1):24-32. PubMed ID: 10713884
[TBL] [Abstract][Full Text] [Related]
28. Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations.
Vink GR; White SJ; Gabelic S; Hogendoorn PC; Breuning MH; Bakker E
Eur J Hum Genet; 2005 Apr; 13(4):470-4. PubMed ID: 15586175
[TBL] [Abstract][Full Text] [Related]
29. Three novel EXT1 and EXT2 gene mutations in Taiwanese patients with multiple exostoses.
Chen WC; Chi CH; Chuang CC; Jou IM
J Formos Med Assoc; 2006 May; 105(5):434-7. PubMed ID: 16638657
[TBL] [Abstract][Full Text] [Related]
30. Multiple osteochondromas: mutation update and description of the multiple osteochondromas mutation database (MOdb).
Jennes I; Pedrini E; Zuntini M; Mordenti M; Balkassmi S; Asteggiano CG; Casey B; Bakker B; Sangiorgi L; Wuyts W
Hum Mutat; 2009 Dec; 30(12):1620-7. PubMed ID: 19810120
[TBL] [Abstract][Full Text] [Related]
31. 20 novel point mutations and one large deletion in EXT1 and EXT2 genes: report of diagnostic screening in a large Italian cohort of patients affected by hereditary multiple exostosis.
Ciavarella M; Coco M; Baorda F; Stanziale P; Chetta M; Bisceglia L; Palumbo P; Bengala M; Raiteri P; Silengo M; Caldarini C; Facchini R; Lala R; Cavaliere ML; De Brasi D; Pasini B; Zelante L; Guarnieri V; D'Agruma L
Gene; 2013 Feb; 515(2):339-48. PubMed ID: 23262345
[TBL] [Abstract][Full Text] [Related]
32. Expression and functional analysis of mouse EXT1, a homolog of the human multiple exostoses type 1 gene.
Lin X; Gan L; Klein WH; Wells D
Biochem Biophys Res Commun; 1998 Jul; 248(3):738-43. PubMed ID: 9703997
[TBL] [Abstract][Full Text] [Related]
33. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
34. Hereditary multiple and isolated sporadic exostoses in the same kindred: identification of the causative gene (EXT2) and detection of a new mutation, nt112delAT, that distinguishes the two phenotypes.
Vujic M; Bergman A; Romanus B; Wahlström J; Martinsson T
Int J Mol Med; 2004 Jan; 13(1):47-52. PubMed ID: 14654969
[TBL] [Abstract][Full Text] [Related]
35. Mutation frequencies of EXT1 and EXT2 in 43 Japanese families with hereditary multiple exostoses.
Seki H; Kubota T; Ikegawa S; Haga N; Fujioka F; Ohzeki S; Wakui K; Yoshikawa H; Takaoka K; Fukushima Y
Am J Med Genet; 2001 Feb; 99(1):59-62. PubMed ID: 11170095
[TBL] [Abstract][Full Text] [Related]
36. Mutation screening of EXT genes in Chinese patients with multiple osteochondromas.
Kang Z; Peng F; Ling T
Gene; 2012 Sep; 506(2):298-300. PubMed ID: 22820392
[TBL] [Abstract][Full Text] [Related]
37. Ext-mutation analysis in Italian sporadic and hereditary osteochondromas.
Gigante M; Matera MG; Seripa D; Izzo AM; Venanzi R; Giannotti A; Digilio MC; Gravina C; Lazzari M; Monteleone G; Monteleone M; Dallapiccola B; Fazio VM
Int J Cancer; 2001 Nov; 95(6):378-83. PubMed ID: 11668521
[TBL] [Abstract][Full Text] [Related]
38. Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas.
Hameetman L; David G; Yavas A; White SJ; Taminiau AH; Cleton-Jansen AM; Hogendoorn PC; Bovée JV
J Pathol; 2007 Mar; 211(4):399-409. PubMed ID: 17226760
[TBL] [Abstract][Full Text] [Related]
39. An extension of the admixture test for the study of genetic heterogeneity in hereditary multiple exostoses.
Legeai-Mallet L; Margaritte-Jeannin P; Lemdani M; Le Merrer M; Plauchu H; Maroteaux P; Munnich A; Clerget-Darpoux F
Hum Genet; 1997 Mar; 99(3):298-302. PubMed ID: 9050912
[TBL] [Abstract][Full Text] [Related]
40. Positional cloning of a gene involved in hereditary multiple exostoses.
Wuyts W; Van Hul W; Wauters J; Nemtsova M; Reyniers E; Van Hul EV; De Boulle K; de Vries BB; Hendrickx J; Herrygers I; Bossuyt P; Balemans W; Fransen E; Vits L; Coucke P; Nowak NJ; Shows TB; Mallet L; van den Ouweland AM; McGaughran J; Halley DJ; Willems PJ
Hum Mol Genet; 1996 Oct; 5(10):1547-57. PubMed ID: 8894688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
